FDA Watching India Pharmaceuticals With a Closer Eye

Share on Facebook
Pharmaceutical companies in India have been subject to more scrutiny and oversight by the U.S. Food and Drug Administration due to recent events of bad practice at a handful of facilities, according to a report by The New York Times.

Read the full story on Becker's Hospital Review.

More Articles on Pharmaceuticals:

Salix Pharmaceuticals Acquires Santarus
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
Valeant Pharmaceuticals International to Acquire Solta Medical for $250M 

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Supply Standardization: 7 Ways to Achieve ASC Physician Buy-In

Read Now